A detailed history of Alerus Financial Na transactions in Novo Nordisk A S stock. As of the latest transaction made, Alerus Financial Na holds 186 shares of NVO stock, worth $11,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186
Holding current value
$11,094
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$58.08 - $81.05 $10,802 - $15,075
186 New
186 $12,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $135B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alerus Financial Na Portfolio

Follow Alerus Financial Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.